These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35020947)

  • 21. Microcystic stromal tumor of the ovary: a recurrent case with somatic CTNNB1 missense mutation.
    Kojima N; Yoshida H; Uno M; Hiranuma K; Naka T; Shiraishi K; Kato T
    Virchows Arch; 2022 Nov; 481(5):799-804. PubMed ID: 35699785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Commonly Exhibits Positivity With Sex Cord Markers FOXL2 and SF-1 but Lacks FOXL2 and DICER1 Mutations.
    Croce S; de Kock L; Boshari T; Hostein I; Velasco V; Foulkes WD; McCluggage WG
    Int J Gynecol Pathol; 2016 Jul; 35(4):301-8. PubMed ID: 26598979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors.
    Zhao C; Vinh TN; McManus K; Dabbs D; Barner R; Vang R
    Am J Surg Pathol; 2009 Mar; 33(3):354-66. PubMed ID: 19033865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β-catenin (CTNNB1) S33C mutation in ovarian microcystic stromal tumors.
    Maeda D; Shibahara J; Sakuma T; Isobe M; Teshima S; Mori M; Oda K; Nakagawa S; Taketani Y; Ishikawa S; Fukayama M
    Am J Surg Pathol; 2011 Oct; 35(10):1429-40. PubMed ID: 21881488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian sex cord-stromal tumors in patients with probable or confirmed germline DICER1 mutations.
    Oost EE; Charles A; Choong CS; Leung YC; Salfinger S; Sonnendecker H; Tan J; Townshend S; Witkowski L; Foulkes WD; Stewart CJ
    Int J Gynecol Pathol; 2015 May; 34(3):266-74. PubMed ID: 25844550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microcystic Stromal Tumor of Testicle: First Case Report and Literature Review.
    Zhu P; Duan Y; Ao Q; Wang G
    Cancer Res Treat; 2018 Oct; 50(4):1452-1457. PubMed ID: 29169232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems.
    Young RH
    Mod Pathol; 2005 Feb; 18 Suppl 2():S81-98. PubMed ID: 15502809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary.
    Al-Agha OM; Huwait HF; Chow C; Yang W; Senz J; Kalloger SE; Huntsman DG; Young RH; Gilks CB
    Am J Surg Pathol; 2011 Apr; 35(4):484-94. PubMed ID: 21378549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms: an immunohistochemical study of 215 cases.
    Movahedi-Lankarani S; Kurman RJ
    Am J Surg Pathol; 2002 Nov; 26(11):1477-83. PubMed ID: 12409724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian microcystic stromal tumor with significant bizarre nuclei: A case report.
    He Y; Xu L; Feng M; Wang W
    Medicine (Baltimore); 2020 Aug; 99(34):e21841. PubMed ID: 32846831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An immunohistochemical and molecular analysis of problematic and unclassified ovarian sex cord-stromal tumors.
    Stewart CJ; Alexiadis M; Crook ML; Fuller PJ
    Hum Pathol; 2013 Dec; 44(12):2774-81. PubMed ID: 24134930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
    McCluggage WG; Young RH
    Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ovarian tumors with endocrine function].
    Guo LN; Liu TH; Sun AJ; Zhou Q
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):217-20. PubMed ID: 15256111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of beta-catenin mutation and SOX9 expression in sex cord-stromal tumours of the testis.
    Bremmer F; Behnes CL; Schildhaus HU; Gaisa NT; Reis H; Jarry H; Radzun HJ; Stroebel P; Schweyer S
    Virchows Arch; 2017 Apr; 470(4):421-428. PubMed ID: 28204871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Practical roles for molecular diagnostic testing in ovarian adult granulosa cell tumour, Sertoli-Leydig cell tumour, microcystic stromal tumour and their mimics.
    Rabban JT; Karnezis AN; Devine WP
    Histopathology; 2020 Jan; 76(1):11-24. PubMed ID: 31846522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signet ring stromal cell tumor revisited and related signet ring cell lesions of the ovary.
    Roth LM; Ramzy I
    Hum Pathol; 2014 Mar; 45(3):636-42. PubMed ID: 24342431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Morphologic and Immunohistochemical Comparison of Nuclear β-Catenin Expressing Testicular Sertoli Cell Tumors and Pancreatic Solid Pseudopapillary Neoplasms Supporting Their Continued Separate Classification.
    Kao CS; Ulbright TM
    Am J Surg Pathol; 2020 Aug; 44(8):1082-1091. PubMed ID: 32604170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors.
    McCluggage WG; McKenna M; McBride HA
    Int J Gynecol Pathol; 2007 Jul; 26(3):322-7. PubMed ID: 17581419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian microcystic stromal tumor: A novel extracolonic tumor in familial adenomatous polyposis.
    Lee SH; Koh YW; Roh HJ; Cha HJ; Kwon YS
    Genes Chromosomes Cancer; 2015 Jun; 54(6):353-60. PubMed ID: 25820106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Constellation of Rare Gynecological Malignancies and Familial Adenomatous Polyposis Gastrointestinal Adenocarcinoma: A Case Report.
    Gill SJ; Pirzada A; Power P; Neveu J
    Int J Gynecol Pathol; 2022 Nov; 41(6):622-627. PubMed ID: 36302191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.